Persbericht Biocartis Group NV: Biocartis kondigt presentatie aan van eerste prospectieve data uit valideringsstudie Merlin Test door partner SkylineDx op EADO 2022 conferentie
21 avr. 2022 01h01 HE
|
Biocartis NV
PERSBERICHT: 21 april 2022, 07:01 CEST Biocartis kondigt presentatie aan van eerste prospectieve data uit valideringsstudie Merlin Test door partner SkylineDx op EADO 2022 conferentie Mechelen,...
Press news Biocartis Group NV: Biocartis Announces Presentation of First Prospective Validation Study Data of Merlin Test by Partner SkylineDx at EADO 2022 Conference
21 avr. 2022 01h01 HE
|
Biocartis NV
PRESS RELEASE: 21 April 2022, 07:01 CEST Biocartis Announces Presentation of First Prospective Validation Study Data of Merlin Test by Partner SkylineDx at EADO 2022 Conference Mechelen, Belgium, 21...
Persbericht Biocartis Group NV: Biocartis rapporteert resultaten eerste kwartaal 2022: Op schema voor het behalen van de vooropgezette jaardoelstellingen, brutomarge op producten van 3%
21 avr. 2022 01h00 HE
|
Biocartis NV
PERSBERICHT: GEREGLEMENTEERDE INFORMATIE 21 april 2022, 07:00 CEST Biocartis rapporteert resultaten eerste kwartaal 2022: Op schema voor het behalen van de vooropgezette jaardoelstellingen,...
Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35%
21 avr. 2022 01h00 HE
|
Biocartis NV
PRESS RELEASE: REGULATED INFORMATION 21 April 2022, 07:00 CEST Biocartis Reports Results of First Quarter of 2022: On Track to Deliver on Full-Year Guidance, Gross Margin on Products of 35% ...
Worldwide Cancer/Tumor Profiling Industry to 2027 - Featuring Abbott Laboratories, Hologic and Illumina Among Others
20 avr. 2022 08h23 HE
|
Research and Markets
Dublin, April 20, 2022 (GLOBE NEWSWIRE) -- The "Cancer/Tumor Profiling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
2022 Insights on the Next-generation Diagnostics Industry - Liquid Biopsy as a Biomarker-driven Tool for Precision Oncology Presents Opportunities
20 avr. 2022 06h33 HE
|
Research and Markets
Dublin, April 20, 2022 (GLOBE NEWSWIRE) -- The "Next-generation Diagnostics Outlook, 2022" report has been added to ResearchAndMarkets.com's offering. In vitro diagnostics introduces new...
Global Tissue Diagnostics Market Report 2022: Market to Reach $4.8 Billion by 2024 - Sustained Advancements in Tissue Diagnostics Space Fuel Market Prospects
18 avr. 2022 07h58 HE
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Tissue Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Tissue Diagnostics...
Global Molecular Diagnostics at the Point of Care Markets, 2022-2027: COVID-19 Pandemic Drives Point of Care Diagnostics into Hypergrowth
18 avr. 2022 04h53 HE
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics at the Point of Care: By Application, Technology, Place, Product and by Country, with COVID-19 PoC Breakout and Executive...
Global Clinical In Vitro Diagnostic Medical Laboratory Services Markets, 2022-2027: Pharmacogenomics, Healthcare Expansion in China, Climate Change, Globalization, Automation
18 avr. 2022 04h43 HE
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry,...
Global In Vitro Diagnostics (IVD) Quality Control Market Growth Forecasts: A $1.54 Billion Market in 2026, with CAGR of 5.7%
15 avr. 2022 04h13 HE
|
Research and Markets
Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics (IVD) Quality Control Global Market Report 2022, By Product Type, Manufacturer Type, Application, End-Users" report has been...